2013 annual financial data

XTL Biopharmaceuticals Ltd. 2013 Operating margin

XTL Biopharmaceuticals Ltd. 2013 operating margin with verified reported values.

Direct answer

Operating margin was -122.16%.

Operating income was -2,894,000 USD and net income was -2,476,000 USD.
Operating cash flow was -2,499,000 USD.

Get free XTL Biopharmaceuticals Ltd. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
2,369,000 USD
Operating income
-2,894,000 USD
Net income
-2,476,000 USD
Operating cash flow
-2,499,000 USD